wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q39767744-551F9F11-0028-4533-95EC-2754BFE40CED
Q39767744-551F9F11-0028-4533-95EC-2754BFE40CED
BestRank
Statement
http://www.wikidata.org/entity/statement/Q39767744-551F9F11-0028-4533-95EC-2754BFE40CED
PIK3CA mutations are associated with reduced pathological complete response rates in primary HER2-positive breast cancer: pooled analysis of 967 patients from five prospective trials investigating lapatinib and trastuzumab.
P2860
Q39767744-551F9F11-0028-4533-95EC-2754BFE40CED
BestRank
Statement
http://www.wikidata.org/entity/statement/Q39767744-551F9F11-0028-4533-95EC-2754BFE40CED
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
8834fbb1b3b8d7ca8b37826826532252f913e739
P2860
Prospective Biomarker Analysis of the Randomized CHER-LOB Study Evaluating the Dual Anti-HER2 Treatment With Trastuzumab and Lapatinib Plus Chemotherapy as Neoadjuvant Therapy for HER2-Positive Breast Cancer